Ceprotin 500 I.E.
Ceprotin 500 I.E. is a medicine authorised by Swissmedic under authorisation number 56124. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 February 2003 and the authorisation is valid without a time limit. ATC code B01AD12 places the medicine in the group Antithrombotic agents.
| Authorisation number | 56124 |
|---|---|
| Name | Ceprotin 500 I.E. |
| Full name | Ceprotin 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Blood products |
| Dispensing category | B · Prescription only |
| ATC code | B01AD12 |
| First authorisation | 25 February 2003 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 3 | Ceprotin 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 14 July 2005 |
| 4 | Ceprotin 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 14 July 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 5 ml | Ampulle(n) | B01AD12 | 06.99.0. | B |
| 3 | 1 x 10 ml | Ampulle(n) | B01AD12 | 06.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ceprotin 500 I.E. authorised in Switzerland?
Yes. Ceprotin 500 I.E. is authorised by Swissmedic under authorisation number 56124, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ceprotin 500 I.E. have?
Ceprotin 500 I.E. is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ceprotin 500 I.E.?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.